Previous Article | Next Article 
Clinical and Vaccine Immunology, February 2009, p. 277-281, Vol. 16, No. 2
1071-412X/09/$08.00+0 doi:10.1128/CVI.00265-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
Heightened Cytotoxic Responses and Impaired Biogenesis Contribute to Early Pathogenesis in the Oral Mucosa of Simian Immunodeficiency Virus-Infected Rhesus Macaques
Michael D. George,*
David Verhoeven,
Sumathi Sankaran,
Tiffany Glavan,
Elizabeth Reay, and
Satya Dandekar
Department of Medical Microbiology, School of Medicine, University of California, Davis, California 95616
Received 11 July 2008/
Returned for modification 25 September 2008/
Accepted 5 December 2008

ABSTRACT
Simian immunodeficiency virus (SIV) infection disseminated into
the oropharyngeal tissues of rhesus macaques 6 weeks following
intravenous inoculation. Severe local CD4
+ T-cell depletion
coincided with increases in NK cell and proinflammatory biomarkers
and the disruption of growth-associated gene transcription,
demonstrating the rapid establishment of pathogenesis in the
oral mucosa.

TEXT
Previous studies of oral mucosal responses to simian immunodeficiency
virus (SIV) infection have generally focused on analyses of
infections that were initiated in the oral cavity (
1,
8,
12).
While evidence suggests that the mechanisms of the immune responses
and the interaction between lymphocytes and the oral epithelium
are impaired as a result of immunodeficiency virus infection
(
2), the characteristics of oral pathogenesis that result from
systemic infection remain largely unknown. We have addressed
some of these questions through the comparative analysis of
oropharyngeal tissues from three healthy SIV-negative rhesus
macaques (animals 30327, 34816, and 34249) and two SIV-infected
animals (animals 33655 and 35182) 6 weeks after intravenous
inoculation with 100 50% tissue culture infective doses of SIV
mac251.
Measurement of SIV replication by reverse transcription (RT-PCR)
(
5) showed that plasma viral loads peaked at about 10
5 to 10
6 RNA copies/ml at 2 weeks postinfection (p.i.) and remained relatively
high at 6 weeks p.i. (Fig.
1A). Through comparisons to standardized
curves generated from known SIV copy numbers, we determined
that the viral loads in oral mucosal tissues were between 10
3 and 10
4 SIV copies/µg of total RNA (Fig.
1B). Immunohistochemical
analysis (
9,
15) showed SIV p27 expression in both macrophages
and CD4
+ T cells that were localized to lymphoid areas in the
oral mucosa (Fig.
1C). Thus, an actively replicating viral reservoir
was established in the oropharynx within 6 weeks of intravenous
SIV inoculation.
To evaluate potential alterations in oral mucosal T-cell homeostasis,
we determined changes in the levels of CD4
+ and CD8
+ T-cell
subsets in SIV-infected animals compared to those in healthy
uninfected controls utilizing the flow cytometry methods described
in our previous studies (
5,
23). While CD4
+ T cells represented
45.4% and 66.6% of the total T-cell population in the oropharynges
of healthy controls (animals 34816 and 34249, respectively),
their numbers appeared to be greatly reduced in SIV-infected
animals (16.1% and 12.4%, respectively) (Fig.
2). As observed
in studies of other mucosal compartments, CD4
+ T-cell depletion
coincided with a proportional increase in the percentage of
CD8
+ T cells (
10,
17,
19,
20). Similar to reports of SIV-infected
gut lymphoid tissue (
7,
18,
21,
22), we found by flow cytometry
increased levels of expression of activation (CD69) and proliferation
(Ki67) biomarkers on the oral mucosal CD4
+ T cells that had
not yet been depleted from the infected animals (data not shown).
Collectively, these data suggest that a massive disruption in
local T-cell homeostasis is associated with the rapid dissemination
of SIV into oropharyngeal tissues.
Mechanisms of host response to SIV in oral mucosa.
To increase our understanding of the mechanisms of the host
response and elucidate the biomarkers of pathogenesis in the
oral mucosa, we compared the gene expression profiles in the
oropharynges of healthy control and SIV-infected animals utilizing
previously reported methods (
5,
6). Briefly, the mean transcription
levels in the oropharyngeal tissues of healthy uninfected animals
(animals 30327, 34816, and 34249) were compared to the corresponding
transcription levels in the SIV-infected animals (animals 33655
and 35182). Genes whose transcription levels were altered by
at least 1.5-fold (up or down) in infected animals (
P 
0.05
by the unpaired Student
t test) were considered for further
evaluation (Fig.
3A). Using these criteria, we determined that
280 genes were upmodulated and that 430 were downmodulated in
the oropharynx as a result of SIV infection. The pathways and
processes that were statistically overrepresented in the filtered
gene set were identified (Fig.
3B). The complete data files
utilized for the microarray analysis are available through the
Gene Expression Omnibus database (GEO14351).
The levels of transcription of genes associated with innate
immunity, inflammation, cell adhesion, and response to wounding
were increased in the oropharyngeal tissues of SIV-infected
animals (Fig.
3B). The innate response category included gamma
interferon and genes associated with interferon induction, antiviral
molecules (e.g., Trim5

), and several NK cell biomarkers (Fig.
4). While many genes regulating NK cell and CD8
+ T-cell functions
overlap (e.g., granzymes and perforin), the added detection
of increases in the levels of expression of NKG2-C, NKG7, and
KIR3DH suggest that both of these cell types may have contributed
to ongoing cytolytic activity in the oropharynges of the SIV-infected
animals. These data are consistent with those reported previously
(
3,
4,
11,
13,
14,
16) and highlight a potentially important
role for NK cells in anti-SIV responses within the oral mucosa.
Taken together, evidence of increased inflammation, elevated
cytolytic activity, and the death of SIV-infected cells also
suggested considerable potential for bystander tissue damage,
a conclusion supported by the upregulation of genes mediating
the response to wounding (Fig.
4).
Downregulation of genes mediating growth in oropharyngeal tissue.
In contrast to the increased levels of expression of genes controlling
defense responses and inflammation, genes mediating biogenesis
pathways, transcriptional regulation, cytoskeletal organization,
tight junction formation, and Wnt pathway signaling were expressed
at considerably lower levels in the SIV-infected animals than
in the healthy uninfected control animals (Fig.
3B). More than
two dozen genes associated with biogenesis were transcriptionally
repressed in the SIV-infected animals. These included genes
involved in B- and T-cell differentiation (c-Maf-inducing protein,
Kruppel-like factor 6), cytoskeletal development (actin, tubulin)
epithelial development (decorin, calmodulin-like 5), muscle
development (myosins, troponins), and neuronal development (BAIAP2,
neurotrimin). A number of genes involved in Wnt signaling were
also downmodulated, highlighted by strong (more than fivefold)
reductions in the levels of expression of casein kinase 1A1,
PPP2R5E, DAAM1, Y-linked transducin, and TCF-4 (Fig.
5).
The cumulative loss of transcription of genes regulating biogenesis
may underscore a reduced capacity for oropharyngeal tissue regeneration
during SIV infection. Logically, an inability to repair early
damage to the oral mucosa could set the stage for continuing
deterioration throughout the course of infection and may ultimately
contribute to an impaired efficacy of the host response to challenge
from secondary opportunistic pathogens. It is important to note,
however, that our findings are based on analyses with a small
number of animals and should therefore be considered preliminary
until larger groups of animals can be evaluated.

ACKNOWLEDGMENTS
We thank Andreas Baumler for supplying oropharyngeal tissues
and the pathologists and animal technicians at the California
National Primate Research Center for their support.
This study was completed through funding (grants 1R21DE018097 and R01DK43183) from the National Institutes of Health.

FOOTNOTES
* Corresponding author. Mailing address: Department of Medical Microbiology and Immunology, University of California, Davis, Room 3318 Tupper Hall, One Shields Ave., Davis, CA 95616. Phone: (530) 752-7207. Fax: (530) 754-7242. E-mail:
mdgeorge{at}ucdavis.edu 
Published ahead of print on 17 December 2008. 

REFERENCES
1 - Abel, K., B. Pahar, K. K. Van Rompay, L. Fritts, C. Sin, K. Schmidt, R. Colon, M. McChesney, and M. L. Marthas. 2006. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses. J. Virol. 80:6357-6367.[Abstract/Free Full Text]
2 - Challacombe, S. J., and S. P. Sweet. 2002. Oral mucosal immunity and HIV infection: current status. Oral Dis. 8(Suppl. 2):55-62.[CrossRef][Medline]
3 - Couedel-Courteille, A., R. Le Grand, M. Tulliez, J. G. Guillet, and A. Venet. 1997. Direct ex vivo simian immunodeficiency virus (SIV)-specific cytotoxic activity detected from small intestine intraepithelial lymphocytes of SIV-infected macaques at an advanced stage of infection. J. Virol. 71:1052-1057.[Abstract]
4 - Genesca, M., P. J. Skinner, J. J. Hong, J. Li, D. Lu, M. B. McChesney, and C. J. Miller. 2008. With minimal systemic T-cell expansion, CD8+ T cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus. J. Virol. 82:11181-11196.[Abstract/Free Full Text]
5 - George, M. D., E. Reay, S. Sankaran, and S. Dandekar. 2005. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration. J. Virol. 79:2709-2719.[Abstract/Free Full Text]
6 - George, M. D., D. Verhoeven, Z. McBride, and S. Dandekar. 2006. Gene expression profiling of gut mucosa and mesenteric lymph nodes in simian immunodeficiency virus-infected macaques with divergent disease course. J. Med. Primatol. 35:261-269.[CrossRef][Medline]
7 - Kaur, A., C. L. Hale, S. Ramanujan, R. K. Jain, and R. P. Johnson. 2000. Differential dynamics of CD4+ and CD8+ T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection. J. Virol. 74:8413-8424.[Abstract/Free Full Text]
8 - Lu, F. X., and R. S. Jacobson. 2007. Oral mucosal immunity and HIV/SIV infection. J. Dent. Res. 86:216-226.[Abstract/Free Full Text]
9 - Macal, M., S. Sankaran, T.-W. Chun, E. Reay, J. Flamm, T. J. Prindiville, and S. Dandekar. 2008. Effective CD4+ T-cell restoration in gut associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol. 1:475-488.[CrossRef][Medline]
10 - Mattapallil, J. J., E. Reay, and S. Dandekar. 2000. An early expansion of CD8alphabeta T cells, but depletion of resident CD8alphaalpha T cells, occurs in the intestinal epithelium during primary simian immunodeficiency virus infection. AIDS 14:637-646.[CrossRef][Medline]
11 - McChesney, M. B., J. R. Collins, and C. J. Miller. 1998. Mucosal phenotype of antiviral cytotoxic T lymphocytes in the vaginal mucosa of SIV-infected rhesus macaques. AIDS Res. Hum Retrovir. 14(Suppl. 1):S63-S66.[Medline]
12 - Milush, J. M., K. Stefano-Cole, K. Schmidt, A. Durudas, I. Pandrea, and D. L. Sodora. 2007. Mucosal innate immune response associated with a timely humoral immune response and slower disease progression after oral transmission of simian immunodeficiency virus to rhesus macaques. J. Virol. 81:6175-6186.[Abstract/Free Full Text]
13 - Murphey-Corb, M., L. A. Wilson, A. M. Trichel, D. E. Roberts, K. Xu, S. Ohkawa, B. Woodson, R. Bohm, and J. Blanchard. 1999. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J. Immunol. 162:540-549.[Abstract/Free Full Text]
14 - Quigley, M. F., K. Abel, B. Zuber, C. J. Miller, J. K. Sandberg, and B. L. Shacklett. 2006. Perforin expression in the gastrointestinal mucosa is limited to acute simian immunodeficiency virus infection. J. Virol. 80:3083-3087.[Abstract/Free Full Text]
15 - Sankaran, S., M. D. George, E. Reay, M. Guadalupe, J. Flamm, T. Prindiville, and S. Dandekar. 2008. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J. Virol. 82:538-545.[Abstract/Free Full Text]
16 - Schmitz, J. E., R. S. Veazey, M. J. Kuroda, D. B. Levy, A. Seth, K. G. Mansfield, C. E. Nickerson, M. A. Lifton, X. Alvarez, A. A. Lackner, and N. L. Letvin. 2001. Simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in gastrointestinal tissues of chronically SIV-infected rhesus monkeys. Blood 98:3757-3761.[Abstract/Free Full Text]
17 - Smit-McBride, Z., J. J. Mattapallil, M. McChesney, D. Ferrick, and S. Dandekar. 1998. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4+ T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J. Virol. 72:6646-6656.[Abstract/Free Full Text]
18 - Sopper, S., U. Sauer, J. G. Muller, C. Stahl-Hennig, and V. ter Meulen. 2000. Early activation and proliferation of T cells in simian immunodeficiency virus-infected rhesus monkeys. AIDS Res. Hum Retrovir. 16:689-697.[CrossRef][Medline]
19 - Veazey, R. S., M. DeMaria, L. V. Chalifoux, D. E. Shvetz, D. R. Pauley, H. L. Knight, M. Rosenzweig, R. P. Johnson, R. C. Desrosiers, and A. A. Lackner. 1998. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280:427-431.[Abstract/Free Full Text]
20 - Veazey, R. S., P. A. Marx, and A. A. Lackner. 2003. Vaginal CD4+ T cells express high levels of CCR5 and are rapidly depleted in simian immunodeficiency virus infection. J. Infect. Dis. 187:769-776.[CrossRef][Medline]
21 - Veazey, R. S., I. C. Tham, K. G. Mansfield, M. DeMaria, A. E. Forand, D. E. Shvetz, L. V. Chalifoux, P. K. Sehgal, and A. A. Lackner. 2000. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4+ T cells are rapidly eliminated in early SIV infection in vivo. J. Virol. 74:57-64.[Abstract/Free Full Text]
22 - Verhoeven, D., S. Sankaran, and S. Dandekar. 2007. Simian immunodeficiency virus infection induces severe loss of intestinal central memory T cells which impairs CD4+ T-cell restoration during antiretroviral therapy. J. Med. Primatol. 36:219-227.[CrossRef][Medline]
23 - Verhoeven, D., S. Sankaran, M. Silvey, and S. Dandekar. 2008. Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4+ T cells in gut mucosa but enhances their rapid restoration through central memory T cells. J. Virol. 82:4016-4027.[Abstract/Free Full Text]
Clinical and Vaccine Immunology, February 2009, p. 277-281, Vol. 16, No. 2
1071-412X/09/$08.00+0 doi:10.1128/CVI.00265-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.